emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

► Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Epsilon M&A Deal Report - Symeres

Transaction Multiples for the Valuation of Private Companies

Private group led by Keensight Capital / Symeres

No EMAT : 120480
Announced Date : 25/05/2021
Type : LBO (Leverage Buy Out) ,Exit
Deal Value : Yes
Acquirer : Private group led by Keensight Capital

Target : Symeres
Country : Netherlands
Sector of activity :
  • Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Created in 2017 by the merger of the CROs Mercachem and Syncom, Symeres, previously known as MercachemSyncom, is a mid-sized European Contract Research Organization for integrated outsourced drug...

Transaction multiples available
EV/
Sales		 EV/
Gross Profit		 EV/
EBITDA		 EV/
EBIT		 Eq/
PBT		 P/E Price
to Book		 Specific
multiple(s)
Historic ns ns ns ns
Current ns ns ns ns
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 37
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
29/06/2022 Private group led by Cathay Capital TransCure bioServices Haute-Savoie *** 120428
10/10/2023 Etap Syncrosome Bouches-Du-Rhône *** 120415

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report